New blood biomarker identified for status of Fatty Liver disease: A MedUni Vienna study team has identified the role of a specific subtype of macrophages (white blood cells) in progressive non-alcoholic Fatty Liver Disease. As part of the immune system, these cells have a protective function against fibrosis and liver cirrhosis. At the same time, they are useful as biomarkers of liver disease progression as they can be measured by a blood test. The results were recently published in the renowned “Journal of Hepatology”. Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide and

New blood biomarker: fatty liver disease as seen on The Hippocratic Post.